Buzz

Join The Family Get The Latest News and Thoughts from ICONYC

Trialjectory
17
December
Buzz |

Trialjectory Uses Self-Reported Clinical Data to Match Cancer Patients With Clinical Trials / Techcrunch

December 17, 2019 by Roni Livneh

Trialjectory, which is developing a new technology service to match cancer patients with clinical trials, has raised $2.7 million to finance its continued growth.

Led by Contour Venture Partners,  the new financing will be used to accelerate Trialjectory’s operations by adding more clinical trials for different cancer types and expanding the company’s outreach to caregivers, pharmaceutical companies and patients, the company said.

“As cancer is the second leading cause of death for Americans — with thousands of new cases diagnosed each year — having access to advanced treatment options is a necessity, not a privilege, as new trials provide better outcomes to patients,” said Tzvia Bader, Trialjectory chief executive and co-founder. “What’s more, one of the top obstacles that oncologists face today is the lack of clinical trial access for patients, which is due to the availability of more treatment options overall. Additionally, it is a very complex process to match the right patient with the right treatment, especially with the rise of personalized medicine.”

The company currently supports trials for breast cancer, colon cancer, bladder cancer, melanoma and myelodysplastic syndromes. Read more. 

More in

Buzz |

Copyleaks, an AI Plagiarism Detection Software, Partners with Macmillan Learning / Yahoo! finance

November 25, 2019 by Roni Livneh
Buzz |

How To Make It As An Israeli Start-Up In New York / Jerusalem Post

October 10, 2017 by Eyal Bino
Buzz |

Introducing The New Generation Of Israeli VC / Forbes

October 3, 2017 by Eyal Bino
Buzz | ,

These Up And Coming Tech Hubs Are Having A Moment With Israeli Tech

October 28, 2020 by Roni Livneh